Orange Book product · Generic (ANDA)
GRISEOFULVIN
GRISEOFULVIN, MICROSIZE
At a glance
Sep 10, 2007
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 10, 2007
19 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
GRISEOFULVIN, MICROSIZE
Strength
125MG/5ML
Dosage form
SUSPENSION
Route
ORAL
TE code
AB
Application
ANDA 065354
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GRISEOFULVIN, MICROSIZE
- 2013GRISEOFULVINGeneric (ANDA)
ANDA 091592 · SANDOZ
- 2012GRISEOFULVINGeneric (ANDA)
ANDA 202482 · SIGMAPHARM LABS LLC
- 2010GRISEOFULVINGeneric (ANDA)
ANDA 065438 · COSETTE PHARMS NC
- 2007GRISEOFULVINGeneric (ANDA)
ANDA 065394 · ACTAVIS MID ATLANTIC
- 2005GRISEOFULVINGeneric (ANDA)
ANDA 065200 · CHARTWELL RX
- 1984GRIFULVIN VGeneric (ANDA)
ANDA 062483 · VALEANT LUXEMBOURG
- —FULVICIN-U/FGeneric (ANDA)
ANDA 060569 · CHARTWELL RX
- —GRIFULVIN VGeneric (ANDA)
ANDA 062279 · VALEANT LUXEMBOURG
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
